Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Advanced Proteome Therapeutics Corporation V.APC.H

Alternate Symbol(s):  APTCF

Advanced Proteome Therapeutics Corporation is actively seeking additional funds to advance its core technologies for partnering and other potential revenue streams. It is not engaged in any activity.


TSXV:APC.H - Post by User

Post by Goldnboy1on May 02, 2021 9:41pm
298 Views
Post# 33112062

No sellers. Hit ask or bust!

No sellers. Hit ask or bust!

Sunday treat for anyone reading this. 

You know when you see a stock that goes bananas and you're like hrmmmmmm. It was trading like 50,000 shares a day before the breakout. Then it trades a few million and re-rates materially. Never returning to the low volume again. As markets take notice of the companies world changing tech.

You say to yourself. Wow. I am just an individual. I could have filled a position in that volume in a day or two had I just found it early enough. Then you watch the stock go on to multiply in just a short period of 4-8-16 months etc. and beyond.

Majority of investors in these markets have this life experience.

Don't let $APC.v. Be that memory for you. ;-)

$APC.v is a conjugation chemotherapy company. They use patented biotechnology to enhance the strength of existing chemotherapy drugs and are trying to invent their own. 

By strengthening the chemo with conjugation. It reduces toxic breakdown contacting healthy cells en route to payload delivery.

The benefit is chemotherapy is more effective and causes less off target toxicity. Which contributes to harmful chemotherapy side effects.

The incoming CEO has spent 15+ years going to Ivey league and industry leading universities in Boston and New York. I think it's important to acknowledge the possibility, that this incoming CEO could have a lot of deep pocketed support behind him.

It's support like that of Wall st, that often extremely legitimate businesses are born from.

Still very early. Get it and forget it!

 

GLTA!
<< Previous
Bullboard Posts
Next >>